Pricing Log in Create free account

Bioventus Inc. (BVS) vs Cytek Biosciences, Inc. (CTKB)

Bioventus Inc. and Cytek Biosciences, Inc. are both Medical Devices companies. Bioventus Inc. is the larger, with a market value of $899.9M against $701.9M — 1.3× the size. Cytek Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Bioventus Inc. trades at 12.3×. Cytek Biosciences, Inc. grew revenue faster over the last twelve months: 5.50% against 3.87%. Bioventus Inc. has the higher net margin (9.78% vs −39.1%) and the higher return on invested capital (7.22% vs −42.1%). Across the 19 metrics below, Bioventus Inc. leads on 14 and Cytek Biosciences, Inc. on 5.

Valuation

Metric BVS CTKB Medical Devices median
P/E 12.32 n/m 25.58
P/S 1.24 3.40 2.54
P/B 2.48 2.20 2.48
Price to free cash flow 8.53 n/m 28.81
EV/EBITDA 9.16 n/m 11.51
EV/Sales 1.58 2.17 2.72
Earnings yield 8.12% (11.62%) (12.82%)
Free cash flow yield 11.73% (1.89%) (8.18%)

Profitability

Metric BVS CTKB Medical Devices median
Gross margin 68.70% 54.75% 57.76%
Operating margin 9.69% (21.13%) (15.07%)
Net margin 9.78% (39.10%) (14.45%)
Free cash flow margin 14.51% (6.43%) (3.88%)
Return on equity 22.96% (23.20%) (10.35%)
Return on assets 8.33% (17.26%) (17.26%)
Return on invested capital 7.22% (42.08%) (5.27%)

Growth

Metric BVS CTKB Medical Devices median
Revenue growth (TTM) 3.87% 5.50% 10.41%
EPS growth (last fiscal year) 158.93% (940.00%) 28.17%
Revenue growth, 5-year CAGR 12.08% 16.76% 15.74%
Net income growth, 5-year CAGR 6.73% 0.00% 0.00%

Health

Metric BVS CTKB Medical Devices median
Debt to equity 0.79 0.00 0.04
Current ratio 1.68 4.46 2.74
Net debt to EBITDA 2.40 9.19 0.54

Dividend

Metric BVS CTKB Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric BVS CTKB Medical Devices median
Market cap 899.91m 701.91m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack